Completed EARLY_PHASE1 INTERVENTIONAL 1-arm NCT04752020

Netarsudil Use After Descemtorhexis Without Endothelial Keratoplasty

Prospective Assessment of Whether Adjuvant Netarsurdil Use Improves Post-Operative Outcomes in Patients Undergoing Descemetorhexis Without Endothelial Keratoplasty

Sponsor: Massachusetts Eye and Ear Infirmary

Conditions Fuchs' Endothelial Dystrophy

Interventions Netarsudil Ophthalmic

Updated 7 times since 2021 Last updated: Mar 11, 2024 Started: Mar 28, 2021 Primary completion: Jun 28, 2023 Completion: Dec 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04752020, this EARLY_PHASE1 trial focuses on Fuchs' Endothelial Dystrophy and remains completed. Sponsored by Massachusetts Eye and Ear Infirmary, it has been updated 7 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Apr 2024 — Jul 2024 [monthly]

Completed EARLY_PHASE1

Status: Active Not Recruiting → Completed
Nov 2023 — Apr 2024 [monthly]

Active Not Recruiting EARLY_PHASE1

Status: Recruiting → Active Not Recruiting
Sep 2022 — Nov 2023 [monthly]

Recruiting EARLY_PHASE1

▶ Show 2 earlier versions

May 2021 — Sep 2022 [monthly]

Recruiting EARLY_PHASE1
Mar 2021 — May 2021 [monthly]

Recruiting EARLY_PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Massachusetts Eye and Ear Infirmary

Data source: Massachusetts Eye and Ear Infirmary

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States